Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target lowered by analysts at Bank of America Corporation from $10.00 to $8.00. They now have a "buy" rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.